Global Allogeneic Cell Therapy market size is expected to reach $1.86 billion by 2029 at 11.5%, segmented as by stem cell therapies, hematopoietic stem cell therapy (hematopoietic stem cells), mesenchymal stem cell therapy (msc-based therapies)
Read MoreGlobal Albumin market size is expected to reach $10.16 billion by 2029 at 9.1%, segmented as by human serum albumin, plasma-derived human serum albumin, recombinant human serum albumin, human serum albumin for therapeutic use (in liver disease
Read MoreGlobal AI-Enabled X-Ray Imaging Solutions market size is expected to reach $4 billion by 2029 at 12.9%, segmented as by product, software, hardware
Read MoreGlobal Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market size is expected to reach $11.53 billion by 2029 at 16.7%, segmented as by gene therapy, viral vectors, non-viral vectors
Read MoreGlobal Adult Spinal Deformity market size is expected to reach $3.27 billion by 2029 at 6.1%, segmented as by scoliosis, idiopathic scoliosis, degenerative scoliosis, neuromuscular scoliosis, congenital scoliosis
Read MoreGlobal Adult Intraventricular Hemorrhage market size is expected to reach $2.82 billion by 2029 at 6.2%, segmented as by surgical devices, craniotomy instruments, external ventricular drainage (evd) systems, surgical clips and staples
Read MoreGlobal Adeno-Associated Viral Vectors market size is expected to reach $6.08 billion by 2029 at 17.6%, segmented as by gene augmentation, inherited genetic disorders, muscular dystrophy, cystic fibrosis, hemophilia
Read MoreGlobal Acute Migraine Treatment market size is expected to reach $4.44 billion by 2029 at 11.2%, segmented as by triptans, sumatriptan, rizatriptan, zolmitriptan, eletriptan
Read MoreGlobal Acoustic Neuroma market size is expected to reach $2.72 billion by 2029 at 8.1%, segmented as by unilateral vestibular schwannomas, small unilateral vestibular schwannomas, medium unilateral vestibular schwannomas
Read MoreGlobal Ablation Technology market size is expected to reach $8.2 billion by 2029 at 8.8%, segmented as by cryoablation devices, cryoprobes, cryoablation catheters
Read More